170 related articles for article (PubMed ID: 37335907)
1. Individual glioblastoma cells harbor both proliferative and invasive capabilities during tumor progression.
Ratliff M; Karimian-Jazi K; Hoffmann DC; Rauschenbach L; Simon M; Hai L; Mandelbaum H; Schubert MC; Kessler T; Uhlig S; Dominguez Azorin D; Jung E; Osswald M; Solecki G; Maros ME; Venkataramani V; Glas M; Etminan N; Scheffler B; Wick W; Winkler F
Neuro Oncol; 2023 Dec; 25(12):2150-2162. PubMed ID: 37335907
[TBL] [Abstract][Full Text] [Related]
2. Tweety-Homolog 1 Drives Brain Colonization of Gliomas.
Jung E; Osswald M; Blaes J; Wiestler B; Sahm F; Schmenger T; Solecki G; Deumelandt K; Kurz FT; Xie R; Weil S; Heil O; Thomé C; Gömmel M; Syed M; Häring P; Huber PE; Heiland S; Platten M; von Deimling A; Wick W; Winkler F
J Neurosci; 2017 Jul; 37(29):6837-6850. PubMed ID: 28607172
[TBL] [Abstract][Full Text] [Related]
3. Time-lapse phenotyping of invasive glioma cells ex vivo reveals subtype-specific movement patterns guided by tumor core signaling.
Fayzullin A; Tuvnes FA; Skjellegrind HK; Behnan J; Mughal AA; Langmoen IA; Vik-Mo EO
Exp Cell Res; 2016 Dec; 349(2):199-213. PubMed ID: 27515001
[TBL] [Abstract][Full Text] [Related]
4. Galectin-1, a gene preferentially expressed at the tumor margin, promotes glioblastoma cell invasion.
Toussaint LG; Nilson AE; Goble JM; Ballman KV; James CD; Lefranc F; Kiss R; Uhm JH
Mol Cancer; 2012 May; 11():32. PubMed ID: 22583806
[TBL] [Abstract][Full Text] [Related]
5. MiR-148a inhibits the proliferation and migration of glioblastoma by targeting ITGA9.
Xu TJ; Qiu P; Zhang YB; Yu SY; Xu GM; Yang W
Hum Cell; 2019 Oct; 32(4):548-556. PubMed ID: 31489579
[TBL] [Abstract][Full Text] [Related]
6. Motility of glioblastoma cells is driven by netrin-1 induced gain of stemness.
Ylivinkka I; Sihto H; Tynninen O; Hu Y; Laakso A; Kivisaari R; Laakkonen P; Keski-Oja J; Hyytiäinen M
J Exp Clin Cancer Res; 2017 Jan; 36(1):9. PubMed ID: 28069038
[TBL] [Abstract][Full Text] [Related]
7. Glioblastoma hijacks neuronal mechanisms for brain invasion.
Venkataramani V; Yang Y; Schubert MC; Reyhan E; Tetzlaff SK; Wißmann N; Botz M; Soyka SJ; Beretta CA; Pramatarov RL; Fankhauser L; Garofano L; Freudenberg A; Wagner J; Tanev DI; Ratliff M; Xie R; Kessler T; Hoffmann DC; Hai L; Dörflinger Y; Hoppe S; Yabo YA; Golebiewska A; Niclou SP; Sahm F; Lasorella A; Slowik M; Döring L; Iavarone A; Wick W; Kuner T; Winkler F
Cell; 2022 Aug; 185(16):2899-2917.e31. PubMed ID: 35914528
[TBL] [Abstract][Full Text] [Related]
8. Tumor cell network integration in glioma represents a stemness feature.
Xie R; Kessler T; Grosch J; Hai L; Venkataramani V; Huang L; Hoffmann DC; Solecki G; Ratliff M; Schlesner M; Wick W; Winkler F
Neuro Oncol; 2021 May; 23(5):757-769. PubMed ID: 33320195
[TBL] [Abstract][Full Text] [Related]
9. [The sodium pump could constitute a new target to combat glioblastomas].
Lefranc F; Mijatovic T; Kiss R
Bull Cancer; 2008 Mar; 95(3):271-81. PubMed ID: 18390407
[TBL] [Abstract][Full Text] [Related]
10. Neural cell adhesion molecule isoform 140 declines with rise of WHO grade in human gliomas and serves as indicator for the invasion zone of multiform glioblastomas and brain metastases.
Duenisch P; Reichart R; Mueller U; Brodhun M; Bjerkvig R; Romeike B; Walter J; Herbold C; Regenbrecht CR; Kalff R; Kuhn SA
J Cancer Res Clin Oncol; 2011 Mar; 137(3):399-414. PubMed ID: 20440511
[TBL] [Abstract][Full Text] [Related]
11. Fibroblast growth factor 13 regulates glioma cell invasion and is important for bevacizumab-induced glioma invasion.
Otani Y; Ichikawa T; Kurozumi K; Inoue S; Ishida J; Oka T; Shimizu T; Tomita Y; Hattori Y; Uneda A; Matsumoto Y; Michiue H; Date I
Oncogene; 2018 Feb; 37(6):777-786. PubMed ID: 29059154
[TBL] [Abstract][Full Text] [Related]
12. Tumor microenvironment tenascin-C promotes glioblastoma invasion and negatively regulates tumor proliferation.
Xia S; Lal B; Tung B; Wang S; Goodwin CR; Laterra J
Neuro Oncol; 2016 Apr; 18(4):507-17. PubMed ID: 26320116
[TBL] [Abstract][Full Text] [Related]
13. DSE promotes aggressive glioma cell phenotypes by enhancing HB-EGF/ErbB signaling.
Liao WC; Liao CK; Tsai YH; Tseng TJ; Chuang LC; Lan CT; Chang HM; Liu CH
PLoS One; 2018; 13(6):e0198364. PubMed ID: 29864158
[TBL] [Abstract][Full Text] [Related]
14. The promoting effect and mechanism of MAD2L2 on stemness maintenance and malignant progression in glioma.
Liu Z; Wang S; Yu K; Chen K; Zhao L; Zhang J; Dai K; Zhao P
J Transl Med; 2023 Nov; 21(1):863. PubMed ID: 38017538
[TBL] [Abstract][Full Text] [Related]
15. Effects of EGF, bFGF, NGF and PDGF(bb) on cell proliferative, migratory and invasive capacities of human brain-tumour biopsies in vitro.
Engebraaten O; Bjerkvig R; Pedersen PH; Laerum OD
Int J Cancer; 1993 Jan; 53(2):209-14. PubMed ID: 8381111
[TBL] [Abstract][Full Text] [Related]
16. Invasive behaviour of human gliomas is mediated by interindividually different integrin patterns.
Tonn JC; Wunderlich S; Kerkau S; Klein CE; Roosen K
Anticancer Res; 1998; 18(4A):2599-605. PubMed ID: 9703915
[TBL] [Abstract][Full Text] [Related]
17. GOLPH3 promotes glioblastoma cell migration and invasion via the mTOR-YB1 pathway in vitro.
Zhang X; Ding Z; Mo J; Sang B; Shi Q; Hu J; Xie S; Zhan W; Lu D; Yang M; Bian W; Zhou X; Yu R
Mol Carcinog; 2015 Nov; 54(11):1252-63. PubMed ID: 25156912
[TBL] [Abstract][Full Text] [Related]
18. Molecular crosstalk between tumour and brain parenchyma instructs histopathological features in glioblastoma.
Bougnaud S; Golebiewska A; Oudin A; Keunen O; Harter PN; Mäder L; Azuaje F; Fritah S; Stieber D; Kaoma T; Vallar L; Brons NH; Daubon T; Miletic H; Sundstrøm T; Herold-Mende C; Mittelbronn M; Bjerkvig R; Niclou SP
Oncotarget; 2016 May; 7(22):31955-71. PubMed ID: 27049916
[TBL] [Abstract][Full Text] [Related]
19. MiR-134 regulates the proliferation and invasion of glioblastoma cells by reducing Nanog expression.
Niu CS; Yang Y; Cheng CD
Int J Oncol; 2013 May; 42(5):1533-40. PubMed ID: 23467648
[TBL] [Abstract][Full Text] [Related]
20. Nuclear FABP7 immunoreactivity is preferentially expressed in infiltrative glioma and is associated with poor prognosis in EGFR-overexpressing glioblastoma.
Liang Y; Bollen AW; Aldape KD; Gupta N
BMC Cancer; 2006 Apr; 6():97. PubMed ID: 16623952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
